-
Chiesi Global Rare Diseases Spotlights the Profound Impact of Epidermolysis Bullosa in the Film “Living Between Pain and Hope” as part of “The Next Frontier,” a New Series Presented by the Biotechnology Innovation Organization
28 Jul 2025 12:00 GMT
… and Michael, both living with epidermolysis bullosa (EB), a rare and devastating … . Explore the series here. About Epidermolysis Bullosa Epidermolysis Bullosa (EB) is a rare and …
-
Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa
25 Jul 2025 13:00 GMT
… wounds in patients with dystrophic epidermolysis bullosa (DEB), starting from birth. … April 2025. JAPAN INDICATION
Dystrophic epidermolysis bullosa About Krystal Biotech, Inc.
… for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly …
-
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
26 Jun 2025 07:03 GMT
… ) — For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical …
-
Cell-based, gene therapy skin grafts heal large epidermolysis bullosa wounds
24 Jun 2025 22:38 GMT
… chronic wounds for patients with epidermolysis bullosa.
The technology could be the … in patients with recessive dystrophic epidermolysis bullosa, according to study results published … in The Lancet.
“Epidermolysis bullosa (EB) is a family of …
-
Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
24 Jun 2025 11:30 GMT
… pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). This article, … Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa Wounds (VIITAL): A … patients with recessive dystrophic epidermolysis bullosa (RDEB). Important Safety …
-
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
24 Jun 2025 11:00 GMT
… of corneal abrasions in dystrophic epidermolysis bullosa (DEB) patients. KB803 is designed … of eye pain and monthly Epidermolysis Bullosa Eye Disease Index (EB-EDI … for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing …
-
Stanford Medicine-led phase 3 trial shows gene therapy skin grafts help epidermolysis bullosa
24 Jun 2025 02:44 GMT
… The grafts treat severe dystrophic epidermolysis bullosa, or EB, a genetic … as butterfly wings
Severe dystrophic epidermolysis bullosa is very rare, affecting …
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two- …
-
Assessing Quality of Life in Patients with Epidermolysis Bullosa in the Saudi Population: Validation of the QOLEB Questionnaire
19 Jun 2025 17:34 GMT
… of the Epidermolysis Bullosa Simplex (EBS) type; Dystrophic Epidermolysis Bullosa (DEB) and Junctional Epidermolysis Bullosa (JEB … usually refers to “inherited epidermolysis bullosa” (or “hereditary epidermolysis bullosa”), and the condition is …
-
Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results
04 Aug 2025 11:00 GMT
… )
for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
The Company recorded $96 … age and older with dystrophic epidermolysis bullosa with mutation(s) in the … for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing …
-
KRYSTAL BIOTECH INC (NASDAQ:KRYS) Q2 2025 Earnings Beat Estimates as VYJUVEK Drives Strong Revenue Growth
04 Aug 2025 12:40 GMT
… gene therapy treatment for dystrophic epidermolysis bullosa (DEB), which recently gained approval …
About
© 1995-2025